➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Dow
Johnson and Johnson
McKesson
Moodys

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ROFLUMILAST

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Roflumilast

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00062582 ↗ Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110) Completed AstraZeneca Phase 3 2003-06-01 The aim of the study is to compare the effect of roflumilast and placebo on the lung function in patients with COPD.
NCT00073177 ↗ Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012) Completed AstraZeneca Phase 3 2003-11-01 The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.
NCT00076076 ↗ The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023) Completed AstraZeneca Phase 3 2003-12-01 The purpose of this study is to confirm the dose of roflumilast to be used for asthma management by comparing the effects of 250 mcg and 500 mcg oral roflumilast with placebo on pulmonary function and asthma symptoms.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Roflumilast

Condition Name

Condition Name for Roflumilast
Intervention Trials
Chronic Obstructive Pulmonary Disease 15
COPD 13
Chronic Obstructive Pulmonary Disease (COPD) 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Roflumilast
Intervention Trials
Pulmonary Disease, Chronic Obstructive 34
Lung Diseases 32
Lung Diseases, Obstructive 30
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Roflumilast

Trials by Country

Trials by Country for Roflumilast
Location Trials
United States 397
Canada 41
United Kingdom 12
Germany 12
Spain 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Roflumilast
Location Trials
Florida 18
California 18
Texas 16
Pennsylvania 14
Kentucky 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Roflumilast

Clinical Trial Phase

Clinical Trial Phase for Roflumilast
Clinical Trial Phase Trials
Phase 4 11
Phase 3 34
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Roflumilast
Clinical Trial Phase Trials
Completed 45
Recruiting 18
Not yet recruiting 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Roflumilast

Sponsor Name

Sponsor Name for Roflumilast
Sponsor Trials
AstraZeneca 27
Takeda 11
Arcutis Biotherapeutics, Inc. 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Roflumilast
Sponsor Trials
Industry 63
Other 46
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Moodys
Express Scripts
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.